Ozempic will give way to another quick-fix diet drug, then another and another, Northeastern expert predicts It may be impossible to avoid the current hype around Ozempic, a new weight-loss promoting drug thats so ubiquitous it ended up mentioned in Jimmy Kimmels Oscar monologue
Clinical Studies 14.1 Cardiovascular Outcomes Trial in Adult Patients with Cardiovascular Disease and Either Obesity or Overweight Overview of Clinical Trial Study 1 (NCT03574597) was a multi-national, multi-center, placebo-controlled, double-blind trial to determine the effect of WEGOVY injection relative to placebo on major adverse CV events (MACE) when added to current standard of care, which included management of CV risk factors and individualized healthy lifestyle counseling (including diet and physical activity) in adults with established CV disease and either obesity or overweight
As employers and their health plans consider whether to pay for Wegovy and other weight management drugs, the decision is complicated by many unknowables concerning their long-term use and whether competition might eventually lower the price
Never discontinue semaglutide without medical guidance, as abrupt cessation may affect glycemic control in patients with diabetes